Foresite Capital Management V as of Sept. 30, 2021
Portfolio Holdings for Foresite Capital Management V
Foresite Capital Management V holds 17 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Somalogic Com Cl A | 20.5 | $66M | 5.3M | 12.39 | |
| Cullinan Oncology (CGEM) | 19.2 | $62M | 2.7M | 22.57 | |
| Adagio Therapeutics (IVVD) | 16.8 | $54M | 1.3M | 42.24 | |
| Aclaris Therapeutics (ACRS) | 7.0 | $23M | 1.3M | 18.00 | |
| Kinnate Biopharma (KNTE) | 6.3 | $20M | 875k | 23.02 | |
| Quantum-Si Incorporated Com Cl A (QSI) | 6.1 | $20M | 2.3M | 8.34 | |
| Cue Health (HLTH) | 4.3 | $14M | 1.2M | 11.81 | |
| Nurix Therapeutics (NRIX) | 4.2 | $14M | 452k | 29.96 | |
| Gemini Therapeutics | 3.1 | $9.8M | 2.4M | 4.04 | |
| Hims & Hers Health Com Cl A (HIMS) | 2.5 | $8.0M | 1.1M | 7.54 | |
| Pharvaris N V (PHVS) | 2.0 | $6.5M | 364k | 17.73 | |
| 23andMe Holding Com Cl A (ME) | 2.0 | $6.3M | 700k | 9.06 | |
| FS Development Corp. II Com Cl A | 1.9 | $6.0M | 603k | 9.95 | |
| Population Health Investment Unit | 1.7 | $5.6M | 960k | 5.84 | |
| Research Alliance Corp. II Com Cl A | 1.5 | $4.9M | 500k | 9.85 | |
| Helix Acquisition Corp. Com Cl A | 0.8 | $2.5M | 250k | 9.95 | |
| Lucira Health | 0.2 | $760k | 485k | 1.57 |
